Anticoagulants and Bleeding Disorders: Clinical Trials

1 trial for Anticoagulants and Bleeding Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Anticoagulants and Bleeding Disorders: new trials by email Literature Review of Anticoagulants and Bleeding Disorders trials Research Report on Anticoagulants and Bleeding Disorders

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
Argatroban, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders
Phase 2 / Phase 3CompletedMedical University of Vienna402021-12-012024-09-19

Narrower conditions

Hemostatic Disorders (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Vascular Diseases (1)

Interventions

Heparin (1)  ·  argatroban (1)

Sponsors

Medical University of Vienna (1)

Countries

Austria (1)

Top investigators

Thomas Staudinger, MD (1)